Jin Zhou

AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial)

Paul Aisen, Jin Zhou, Michael C. Irizarry et al. · Alzheimer s & Dementia · 2020 · 23 citations · Full text

Medicine, Neurology, Neuroscience +17

Increased procoagulant activity of red blood cells in the presence of cisplatin

Chengfang Lu, Hongjuan Yu, Jinxiao Hou et al. · Chinese Medical Journal · 2008 · 15 citations · Full text

Medicine, Hematology, Oncology +13

Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid‐positive early Alzheimer's disease

Viswanath Devanarayan, Arnaud Charil, Kanta Horie et al. · Alzheimer s & Dementia · 2024 · 15 citations · Full text

Medicine, Neurology, Neuroscience +17

An Anti-tau Therapeutic Antibody Etalanetug (E2814)

Sumit Rawal, Kristin R. Wildsmith, Jagadeesh Aluri et al. · Alzheimer Disease & Associated Disorders · 2025 · 13 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

E2814: an anti‐tau therapy engages its CNS target and affects the downstream tangle‐specific biomarker MTBR‐tau243 in Dominantly Inherited Alzheimer’s Disease

Jin Zhou, Sumit Rawal, Takuya Yagi et al. · Alzheimer s & Dementia · 2023 · 10 citations · Full text

Medicine, Neurology, Pharmacology +17